Publicacións en colaboración con investigadores/as de Hospital Universitari de Bellvitge (20)

2024

  1. Spanish cardiac catheterization and coronary intervention registry. 33rd official report of the Interventional Cardiology Association of the Spanish Society of Cardiology (1990-2023)

    Revista Espanola de Cardiologia

2023

  1. Trends in cardiovascular care in the National Health System in Spain. Data from the RECALCAR project 2011-2020

    Revista Espanola de Cardiologia, Vol. 76, Núm. 7, pp. 519-530

2022

  1. Vascular healing responses to paclitaxel coated balloons or everolimus eluting stents for the treatment of in-stent restenosis. Insights from optical coherence tomography

    Coronary Artery Disease, Vol. 33, Núm. 8, pp. 609-617

2021

  1. Influence of neoatherosclerosis on prognosis and treatment response in patients with in-stent restenosis

    Revista Espanola de Cardiologia, Vol. 74, Núm. 5, pp. 427-435

  2. Thin- versus thick-strut polymer-free biolimus-eluting stents: The BioFreedom QCA randomised trial

    EuroIntervention, Vol. 17, Núm. 3, pp. 233-239

2020

  1. Coronary artery aneurysms, insights from the international coronary artery aneurysm registry (CAAR)

    International Journal of Cardiology, Vol. 299, pp. 49-55

  2. Role of coronary angiography in patients with a non-diagnostic electrocardiogram following out of hospital cardiac arrest: Rationale and design of the multicentre randomized controlled COUPE trial

    European Heart Journal: Acute Cardiovascular Care, Vol. 9, Núm. 4_suppl, pp. S131-S137

2019

  1. Long-term impact of diabetes in patients with ST-segment elevation myocardial infarction: Insights from the EXAMINATION randomized trial

    Catheterization and Cardiovascular Interventions, Vol. 94, Núm. 7, pp. 917-925

2018

  1. 3-Year Clinical Follow-Up of the RIBS IV Clinical Trial: A Prospective Randomized Study of Drug-Eluting Balloons Versus Everolimus-Eluting Stents in Patients With In-Stent Restenosis in Coronary Arteries Previously Treated With Drug-Eluting Stents

    JACC: Cardiovascular Interventions, Vol. 11, Núm. 10, pp. 981-991

2017

  1. Impact of Chronic Total Coronary Occlusion on Recurrence of Ventricular Arrhythmias in Ischemic Secondary Prevention Implantable Cardioverter-Defibrillator Recipients (VACTO Secondary Study): Insights From Coronary Angiogram and Electrogram Analysis

    JACC: Cardiovascular Interventions, Vol. 10, Núm. 9, pp. 879-888

2015

  1. A Prospective Randomized Trial of Drug-Eluting Balloons Versus Everolimus-Eluting Stents in Patients with In-Stent Restenosis of Drug-Eluting Stents the RIBS IV Randomized Clinical Trial

    Journal of the American College of Cardiology, Vol. 66, Núm. 1, pp. 23-33

  2. Cost-effectiveness of a European ST-segment elevation myocardial infarction network: Results from the Catalan Codi Infart network

    BMJ Open, Vol. 5, Núm. 12

  3. Rationale and design of the RIBS IV randomised clinical trial (drug-eluting balloons versus everolimus-eluting stents for patients with drug-eluting stent restenosis)

    EuroIntervention, Vol. 11, Núm. 3, pp. 336-342

2014

  1. A randomized comparison of drug-eluting balloon versus everolimus-eluting stent in patients with bare-metal stent-in-stent restenosis: The RIBS v clinical trial (restenosis intra-stent of bare metal stents: Paclitaxel-eluting balloon vs. everolimus-eluting stent)

    Journal of the American College of Cardiology, Vol. 63, Núm. 14, pp. 1378-1386

2011

  1. Primary angioplasty vs. fibrinolysis in very old patients with acute myocardial infarction: TRIANA (TRatamiento del Infarto Agudo de miocardio en Ancianos) randomized trial and pooled analysis with previous studies

    European Heart Journal, Vol. 32, Núm. 1, pp. 51-60

2006

  1. A Randomized Comparison of Sirolimus-Eluting Stent With Balloon Angioplasty in Patients With In-Stent Restenosis. Results of the Restenosis Intrastent: Balloon Angioplasty Versus Elective Sirolimus-Eluting Stenting (RIBS-II) Trial

    Journal of the American College of Cardiology, Vol. 47, Núm. 11, pp. 2152-2160

  2. Eficacia de la implantación del stent recubierto de rapamicina en pacientes diabéticos con vasos muy pequeños (≤2,25 mm). Subanálisis del estudio DIABETES

    Revista Espanola de Cardiologia, Vol. 59, Núm. 10, pp. 1000-1007

  3. Value of the American College of Cardiology/American Heart Association angiographic classification of coronary lesion morphology in patients with in-stent restenosis: Insights from the Restenosis Intra-stent Balloon angioplasty versus elective Stenting (RIBS) randomized trial

    American Heart Journal, Vol. 151, Núm. 3, pp. 681.e1-681.e9

2003

  1. A randomized comparison of repeat stenting with balloon angioplasty in patients with in-stent restenosis

    Journal of the American College of Cardiology, Vol. 42, Núm. 5, pp. 796-805

2000

  1. Stenting the stent: Initial results and long-term clinical and angiographic outcome of coronary stenting for patients with in-stent restenosis

    American Journal of Cardiology, Vol. 85, Núm. 3, pp. 327-332